Revision history of "Lenvatinib in addition TACE without or with pembrolizumab to treat in the beginning unresectable hepatocellular carcinoma harbouring PDL1 phrase the retrospective study"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 10:08, 8 May 2024‎ Calfliquid38 (Talk | contribs)‎ . . (3,416 bytes) (+3,416)‎ . . (Created page with "Fifty one dB, 0.All day and ps3, Several.07 Tb/s, and $148\;\unicodex00B5 \rm m^2$148µm2, correspondingly. In addition to these kinds of variables, a couple of fresh guidelin...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Lenvatinib_in_addition_TACE_without_or_with_pembrolizumab_to_treat_in_the_beginning_unresectable_hepatocellular_carcinoma_harbouring_PDL1_phrase_the_retrospective_study"